FIGO Classification MRI: Radiation Oncology Agreement
- A new study published October 10, 2024, in Fertility and Sterility reveals moderate interobserver agreement among radiologists using the FIGO classification system to categorize uterine fibroids on MRI...
- Published by Fertility and Sterility, the research highlights potential limitations of the system, especially in complex cases.
- Researchers, led by Cibele Luna, MD, from the University of miami in Florida, investigated how consistently radiologists classify uterine fibroids using the International Federation of Gynecology and Obstetrics...
“`html
Radiologist Agreement Moderate in Classifying Uterine Fibroids on MRI
Table of Contents
A new study published October 10, 2024, in Fertility and Sterility reveals moderate interobserver agreement among radiologists using the FIGO classification system to categorize uterine fibroids on MRI scans.
Published by Fertility and Sterility, the research highlights potential limitations of the system, especially in complex cases.
Study Findings: Moderate Agreement, Experience Doesn’t Matter
Researchers, led by Cibele Luna, MD, from the University of miami in Florida, investigated how consistently radiologists classify uterine fibroids using the International Federation of Gynecology and Obstetrics (FIGO) system on MRI. The study found moderate interobserver agreement,meaning radiologists don’t always agree on the specific type of fibroid based on the scans.
Interestingly, the team reported no statistically significant difference in confidence scores between radiologists with varying levels of experience (p = 0.9). This suggests that experience alone doesn’t necessarily improve consistency when applying the FIGO system to MRI interpretation.
The FIGO System and Its Limitations
The FIGO system is a widely used tool for categorizing the location of uterine fibroids. Tho, the authors suggest its request to MRI might potentially be limited, especially when dealing with complex or ambiguous cases. The system may not adequately capture the nuances visible on MRI, leading to differing interpretations.
Uterine fibroids are noncancerous growths in the uterus that can cause heavy menstrual bleeding, pelvic pain, and infertility. Accurate classification is crucial for determining the most appropriate treatment strategy, ranging from medical management to surgical intervention.
Future Research Directions
The study authors recommend future multicenter studies to address the identified limitations. Thes studies could focus on:
- Refining existing classification systems to improve interobserver reliability.
- Assessing the role of alternative imaging modalities,such as ultrasound or intraoperative imaging.
- Exploring subtype-specific assessment, potentially including an “unclassifiable” category for cases where a definitive diagnosis is challenging.
understanding Uterine Fibroids
Uterine fibroids are common,affecting an estimated 30% of women by age 30 and up to 70% by age 50. They vary in size,
